Insiders are snapping up a large amount of stock in Verenium (VRNM), which manufactures and markets its enzyme products in the fields of animal health and nutrition, grain processing, oilseed processing and other markets, such as oilfield services, pulp and paper and textiles. Insiders are buying into some big time strength here since the stock is up over 93% so far in 2012.
Verenium has a market cap of $53 million and an enterprise value of $57.79 million. This stock trades at a reasonable valuation, with a trailing price-to-earnings 10.34. Its estimated growth rate for this year is 12%, and for next year it's pegged at 30.3%. This is not a cash-rich company, since the total cash position on its balance sheet is $28.76 million and its total debt is $34.85 million. After you back out the cash, Verenium has $6.09 million in debt on its books.A beneficial owner just bought 389,528 shares, or about $1.48 million worth of stock, at $3.76 to $3.97 per share. >>10 Small-Cap Stocks Safe for Skittish Investors From a technical perspective, VRNM is currently trading above both its 50-day and 200-day moving averages, which is bullish. This stock has been trending strong since the start of the year, with shares soaring from a low of $2.14 to a recent high of $4.38 a share. That move has pushed the stock within range of triggering a major breakout trade if a number of past overhead resistance levels can get taken out with volume. If you like the look of VRNM, I would consider long-biased trades if this stock can manage to break out above $4.38 to $4.68 a share with high-volume. Look for volume on that move that's near or well above its three-month average action of 109,102 shares. If we get that action soon, then VRNM could start to trend back towards its next major overheard resistance levels at $6 to $6.65 a share. It's important that VRNM gets above $4.38 to $4.68 with volume soon and continues to trend above those levels if it's going to make a big run in the near future. A failure to hold or break out above those levels will mean VRNM isn't ready and will likely fall back below Wednesday's low of $3.78.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV